S455 Efficacy and Safety of the Selective Sphingosine 1-Phosphate Receptor Modulator, Etrasimod, in Adult Patients With Eosinophilic Esophagitis: Primary Results From the Phase 2 VOYAGE StudyEvan S. Dellon, Ikuo Hirano, Luc Biedermann et al.|The American Journal of Gastroenterology|2023Cited by 10
635 EFFICACY AND SAFETY OF THE SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, ETRASIMOD, IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS OVER 52 WEEKS IN THE PHASE 2 VOYAGE STUDYEvan S. Dellon, Ikuo Hirano, Margaret H. Collins et al.|Gastroenterology|2024Cited by 3